Valeriana Cesarini
After earning her Master’s degree in Medical Biotechnology (2011) at the Catholic University of the Sacred Heart in Rome, with a thesis carried out at the Institute of Molecular Pathology on the molecular prognostic determinants of Hodgkin lymphoma, she continued her training in the Department of Neurosurgery of the same University, working on the characterisation of cancer stem cells isolated from patients with glioblastoma. In 2015 she obtained her PhD in Biotechnology and Translational Medicine at the University of Rome Tor Vergata, at the Institute of Human Anatomy, where she investigated the molecular mechanisms governing glioblastoma invasiveness and melanoma development.
From 2016 to 2020 she was a postdoctoral researcher at the Department of Onco-Haematology of the Bambino Gesù Children’s Hospital in Rome, where she specialised in post-transcriptional modifications, studying the role of the ADAR2 enzyme as a tumour suppressor in glioblastoma using mouse models.
Since 2019 she has been Lecturer in Human Anatomy at UniCamillus, teaching in the degree programmes in Medicine and Surgery (2019–2022) and in Dentistry and Dental Prosthetics (since 2021). At the same University she held a fixed-term Assistant Professor position (RTDA, type A) in Human Anatomy (SSD BIOS-12/A) in 2020. Since July 2020 she has held a tenured Researcher position at the National Research Council of Italy (CNR), and carries out her work at the Institute of Genetic and Biomedical Research (IRGB), based at IRCCS Humanitas Research Hospital in Milan.
Her research centres on the role of A-to-I RNA editing, mediated by ADAR enzymes, in cancer and cardiovascular disease, with particular attention to ascending thoracic aortic aneurysms and heart failure. She is currently Principal Investigator of a three-year project (2026–2029) funded by the Italian Ministry of Health. The project investigates how RNA editing drives cardiac remodelling and whether modulating it can open new therapeutic strategies. She is the author of over thirty peer-reviewed publications in international journals, including Nature, Immunity, Genome Biology and Nucleic Acids Research, in several cases as first, last or corresponding author. She is co-inventor of a national patent covering an aptamer conjugated to an edited microRNA and its therapeutic uses. She serves on the editorial board of International Journal of Molecular Sciences and as Reviewer Editor for Frontiers in Genetics and Frontiers in Molecular Biosciences.



